CD79A and COVID-19: Circulating RBD IgA had an estimated initial t1/2 of 27 days, decaying by ~90 days in most COVID-19 cases to levels indistinguishable from uninfected controls (Fig. 1K), consistent with observations 3 months PSO (44, 49).